Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us

Download Mobile App




Urine Protein Test Can Predict Dementia Risk

By LabMedica International staff writers
Posted on 26 Sep 2025

Dementia remains one of the most pressing health challenges worldwide, with age as the greatest risk factor. More...

Increasingly, research suggests that diseases in other organs, such as the kidneys, may play a role in its development. Identifying markers that link kidney health to brain function could provide an early warning for cognitive decline. Now, a new study has shown that a common protein found in urine may indicate an increased risk of developing dementia later in life.

The study, conducted by researchers at Karolinska Institutet (Stockholm, Sweden), investigated the role of albuminuria—an abnormal condition where the protein albumin leaks into urine. Normally, healthy kidneys filter waste products while keeping essential proteins like albumin in the blood. Elevated albumin levels indicate kidney damage and, according to this research, may also reflect vascular changes that predispose individuals to dementia.

Researchers followed 130,000 adults aged over 65 in Stockholm who were free of dementia at baseline. Over four years, 7 percent developed dementia. After adjusting for kidney function and other health factors, results showed that those with moderate albuminuria (30–299 mg/g) had a 25 percent higher risk of dementia, while those with high levels (≥300 mg/g) had a 37 percent greater risk compared to participants with normal albumin levels.

The association was particularly strong for vascular dementia, often caused by stroke, high blood pressure, diabetes, or vascular disease, and for mixed dementia, which combines vascular and Alzheimer’s features. The findings, published in the Journal of Internal Medicine, highlight how kidney dysfunction may mirror damage in the brain’s small vessels, influencing the blood-brain barrier and increasing the risk of harmful protein buildup linked to dementia.

The study underscores the potential of routine screening for albuminuria in older adults and in patients with conditions like hypertension, diabetes, cardiovascular disease, or kidney disease. Detecting the condition early could allow for preventive interventions to reduce or delay dementia onset. Researchers suggest integrating this simple urine test into dementia risk assessments to improve outcomes and reduce disease burden.

"These results underscore the importance of routine screening for albuminuria as part of early dementia risk assessment, especially in patients with high blood pressure, diabetes, cardiovascular disease, or kidney disease,” said Hong Xu, assistant professor at Karolinska Institutet and last author of the study. “Early detection of albuminuria could potentially delay or prevent the onset of dementia."

Related Links:
Karolinska Institutet


Gold Member
Cardiovascular Risk Test
Metabolic Syndrome Array I & II
Collection and Transport System
PurSafe Plus®
New
CBM Analyzer
Complete Blood Morphology (CBM) Analyzer
Rapid Molecular Testing Device
FlashDetect Flash10
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Hematology

view channel
Image: New evidence shows viscoelastic testing can improve assessment of blood clotting during postpartum hemorrhage (Photo courtesy of 123RF)

Viscoelastic Testing Could Improve Treatment of Maternal Hemorrhage

Postpartum hemorrhage, severe bleeding after childbirth, remains one of the leading causes of maternal mortality worldwide, yet many of these deaths are preventable. Standard care can be hindered by delays... Read more

Immunology

view channel
Image: The CloneSeq-SV approach can allow researchers to study how cells within high-grade serous ovarian cancer change over time (Photo courtesy of MSK)

Blood Test Tracks Treatment Resistance in High-Grade Serous Ovarian Cancer

High-grade serous ovarian cancer (HGSOC) is often diagnosed at an advanced stage because it spreads microscopically throughout the abdomen, and although initial surgery and chemotherapy can work, most... Read more

Industry

view channel
Image: The collaboration aims to improve access to Hb variant testing with the Gazelle POC diagnostic platform (Photo courtesy of Hemex Health)

Terumo BCT and Hemex Health Collaborate to Improve Access to Testing for Hemoglobin Disorders

Millions of people worldwide living with sickle cell disease and other hemoglobin disorders experience delayed diagnosis and limited access to effective care, particularly in regions where testing is scarce.... Read more
Copyright © 2000-2025 Globetech Media. All rights reserved.